Debbie Croom-Carter

Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death

S. A. Henderson, Martin Rowe, C D Gregory et al. · Cell · 1991 · 1.2K citations

Apoptosis, Immunology, B Cells +8

The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.

David Huen, S A Henderson, Debbie Croom-Carter et al. · PubMed · 1995 · 463 citations

Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes

Martin Rowe, Andrea Lear, Debbie Croom-Carter et al. · Journal of Virology · 1992 · 357 citations · Full text

Lymphoid Neoplasia, Cancer-associated Virus, Epstein-barr Virus +14

Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers

Martin Rowe, M. Peng-Pilon, David Huen et al. · Journal of Virology · 1994 · 202 citations · Full text

Humoral Response, Immunology, Viral Pathogenesis +18

The Importance of Exogenous Antigen in Priming the Human CD8+ T Cell Response: Lessons from the EBV Nuclear Antigen EBNA1

Neil Blake, Tracey A. Haigh, Ghadeer Shaka’a et al. · The Journal of Immunology · 2000 · 129 citations · Full text